Nonalcoholic Fatty Liver Disease in Taiwanese Children
NCT00274183 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 614
Last updated 2019-04-09
Summary
Nonalcoholic fatty liver disease (NAFLD) is an emerging and important disease in Taiwan. However, the prevalence and clinical characteristics have not been studied well. The purpose of this study is to resolve the aforementioned problem.
Conditions
Sponsors & Collaborators
-
Far Eastern Memorial Hospital
lead OTHER
Principal Investigators
-
Yu-Cheng Lin, M.D. · Far Eastern Memorial Hospital
Eligibility
- Min Age
- 6 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-01-31
- Primary Completion
- 2018-12-31
- Completion
- 2018-12-31
Countries
- Taiwan
Study Locations
More Related Trials
-
Heritability of Fatty Liver as Measured by MRI: a Cross Sectional Study of Twins and Family Members
NCT01643512 ·Status: UNKNOWN
-
An Imaging-based Quantitative Biomarker Assay for NAFLD in Children
NCT06354491 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Mapping of Metabolic Liver Functions in Patients With Non-alcoholic Fatty Liver Disease
NCT02488941 ·Status: UNKNOWN
-
Natural History of Non Alcoholic Fatty Liver Disease and Predictors of Advanced Fibrosis
NCT05050721 ·Status: WITHDRAWN
-
Dynamic Contrast-enhanced Magnetic Resonance Imaging in Evaluation of Liver Functional Status and Treatment Efficacy in Patients With Hepatocellular Carcinoma After Locoregional Therapy
NCT01281683 ·Status: UNKNOWN
-
Use of Shear Wave Elastography to Assess Non-alcoholic Fatty Liver Disease (NAFLD)
NCT03587298 ·Status: UNKNOWN
-
Risk Factors for Hepatic Inflammation, Fibrosis and Prognosis in Patients With CHB and NAFLD
NCT05766449 ·Status: RECRUITING
-
Searching for the Liver Cancer-Related Biomarkers
NCT00154544 ·Status: UNKNOWN
-
Ultrasound Liver Fat Quantification on Pediatric Patients
NCT06095479 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Treatment Response With Integrated MRI/PET in Patients With Hepatocellular Carcinoma
NCT02550613 ·Status: UNKNOWN
-
Liver Fibrosis in Peri-menopausal Women
NCT03602573 ·Status: UNKNOWN
-
Monitoring Changes in Hepatic Steatosis Using Continuous Controlled Attenuation Parameter
NCT06203548 ·Status: RECRUITING ·Phase: NA
-
Prospective Cohort Study in Patients With NAFLD
NCT00575133 ·Status: RECRUITING
-
Utilizing Non-Invasive Fibroscan® Technology to Identify Genetic Markers for Fatty Liver Progression
NCT02267148 ·Status: COMPLETED
-
Methods to Detect Liver Fibrosis
NCT03027700 ·Status: TERMINATED ·Phase: NA
-
Prospective Cohort Study of Association of Insulin Resistance/Steatosis With Hepatic Fibrosis in CHB and NAFLD
NCT02031913 ·Status: COMPLETED
-
NAFLD Primary Care
NCT04918732 ·Status: RECRUITING ·Phase: NA
-
To Explore the Value of New MR Technology in Non-invasive Quantitative Assessment of Systemic Metabolism, Disease Status and Prognosis in Patients With Metabolic-Associated Fatty Liver Disease
NCT07149571 ·Status: RECRUITING
-
Non-invasive Diagnostic Model of Liver Fibrosis Associated With NAFLD and Prediction of Prognosis
NCT03842748 ·Status: UNKNOWN
-
C1q/TNF-related Proteins in Non-Alcoholic Fatty Liver Disease
NCT02083159 ·Status: UNKNOWN
-
Longitudinal Observational Study Of Chinese With NAFLD/NASH
NCT03151473 ·Status: RECRUITING
-
Prevalence of NAFLD and Correlation With Its Main Risk Factors Among Egyptian
NCT04081571 ·Status: UNKNOWN
-
The Influence of Autophagy on Fatty Liver
NCT01988441 ·Status: UNKNOWN
-
Screening of Liver Fibrosis Using Blood Tests in Patients With Type 2 Diabetes Mellitus
NCT04232293 ·Status: COMPLETED ·Phase: NA
-
Application of the Stem Cell Therapy in the End Stage Liver Disease and Assessment Its Consequences in the Quality of Live Style as Well as Development of HCC.
NCT01729221 ·Status: UNKNOWN